Summary

The global market for Implantable Drug Delivery Devices was estimated to be worth US$ 569 million in 2024 and is forecast to a readjusted size of US$ 693 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.
An Implantable Drug Delivery Device is a fully implanted medical device used for long-term intravenous therapy, such as chemotherapy, parenteral nutrition, and repeated blood sampling. It consists of a small reservoir (port) placed under the skin, usually in the chest, connected to a catheter that enters a central vein. This design allows healthcare professionals to access the bloodstream without repeated needle insertions into peripheral veins, reducing discomfort and the risk of vascular complications.
Implantable Drug Delivery Device are commonly used for patients requiring frequent or prolonged intravenous treatments, offering advantages such as improved patient mobility, a lower infection risk compared to external catheters, and enhanced durability. The device is accessed through the skin using a special non-coring needle, ensuring a secure and reliable administration route. Advances in biomaterials and catheter technology have improved the safety and efficiency of TIVADs, making them a standard choice for patients undergoing long-term infusion therapy.
The Implantable Drug Delivery Device market is driven by the increasing prevalence of chronic diseases such as cancer, which requires long-term intravenous therapy. The rising global cancer burden, coupled with the growing demand for chemotherapy and parenteral nutrition, has significantly boosted Implantable Drug Delivery Device adoption. Additionally, advancements in biomaterials and catheter technologies have improved device safety, reducing infection risks and enhancing patient comfort. Healthcare infrastructure improvements, increased awareness, and expanding insurance coverage further contribute to market growth, especially in emerging economies where access to advanced medical treatments is improving.
However, the market faces several challenges, including high device costs and procedural expenses, which limit accessibility, particularly in developing regions. Complications such as infections, thrombosis, and catheter malfunctions remain concerns, requiring strict adherence to insertion and maintenance protocols. Moreover, the need for trained medical professionals for implantation and management can hinder widespread adoption. Regulatory requirements and lengthy approval processes for new Implantable Drug Delivery Device innovations also pose market entry barriers. Despite these challenges, continued technological advancements and increasing healthcare investments are expected to drive market expansion in the coming years.
The global key manufacturers of Implantable Drug Delivery Device include BD, B. Braun, ICU Medical, AngioDynamics, Linhua Medical, etc. In 2024, the global top five players had a share approximately 83.54% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Implantable Drug Delivery Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implantable Drug Delivery Devices by region & country, by Type, and by Application.
The Implantable Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Drug Delivery Devices.
Market Segmentation
By Company
BD
B.Braun
AngioDynamics
ICU Medical
Fresenius
Vygon
PFM Medical
Districlass
Linhwa
Sophysa
Baxter
PakuMed
Segment by Type
Titanium Drug Delivery System
Plastic Drug Delivery System
Segment by Application
Intravenous Chemotherapy
Nutrition Support Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Implantable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Implantable Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Implantable Drug Delivery Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Implantable Drug Delivery Devices Product Introduction
1.2 Global Implantable Drug Delivery Devices Market Size Forecast
1.2.1 Global Implantable Drug Delivery Devices Sales Value (2020-2031)
1.2.2 Global Implantable Drug Delivery Devices Sales Volume (2020-2031)
1.2.3 Global Implantable Drug Delivery Devices Sales Price (2020-2031)
1.3 Implantable Drug Delivery Devices Market Trends & Drivers
1.3.1 Implantable Drug Delivery Devices Industry Trends
1.3.2 Implantable Drug Delivery Devices Market Drivers & Opportunity
1.3.3 Implantable Drug Delivery Devices Market Challenges
1.3.4 Implantable Drug Delivery Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Implantable Drug Delivery Devices Players Revenue Ranking (2024)
2.2 Global Implantable Drug Delivery Devices Revenue by Company (2020-2025)
2.3 Global Implantable Drug Delivery Devices Players Sales Volume Ranking (2024)
2.4 Global Implantable Drug Delivery Devices Sales Volume by Company Players (2020-2025)
2.5 Global Implantable Drug Delivery Devices Average Price by Company (2020-2025)
2.6 Key Manufacturers Implantable Drug Delivery Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Implantable Drug Delivery Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Implantable Drug Delivery Devices
2.9 Implantable Drug Delivery Devices Market Competitive Analysis
2.9.1 Implantable Drug Delivery Devices Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Implantable Drug Delivery Devices Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Drug Delivery Devices as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Titanium Drug Delivery System
3.1.2 Plastic Drug Delivery System
3.2 Global Implantable Drug Delivery Devices Sales Value by Type
3.2.1 Global Implantable Drug Delivery Devices Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Implantable Drug Delivery Devices Sales Value, by Type (2020-2031)
3.2.3 Global Implantable Drug Delivery Devices Sales Value, by Type (%) (2020-2031)
3.3 Global Implantable Drug Delivery Devices Sales Volume by Type
3.3.1 Global Implantable Drug Delivery Devices Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Implantable Drug Delivery Devices Sales Volume, by Type (2020-2031)
3.3.3 Global Implantable Drug Delivery Devices Sales Volume, by Type (%) (2020-2031)
3.4 Global Implantable Drug Delivery Devices Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Intravenous Chemotherapy
4.1.2 Nutrition Support Therapy
4.2 Global Implantable Drug Delivery Devices Sales Value by Application
4.2.1 Global Implantable Drug Delivery Devices Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Implantable Drug Delivery Devices Sales Value, by Application (2020-2031)
4.2.3 Global Implantable Drug Delivery Devices Sales Value, by Application (%) (2020-2031)
4.3 Global Implantable Drug Delivery Devices Sales Volume by Application
4.3.1 Global Implantable Drug Delivery Devices Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Implantable Drug Delivery Devices Sales Volume, by Application (2020-2031)
4.3.3 Global Implantable Drug Delivery Devices Sales Volume, by Application (%) (2020-2031)
4.4 Global Implantable Drug Delivery Devices Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Implantable Drug Delivery Devices Sales Value by Region
5.1.1 Global Implantable Drug Delivery Devices Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Implantable Drug Delivery Devices Sales Value by Region (2020-2025)
5.1.3 Global Implantable Drug Delivery Devices Sales Value by Region (2026-2031)
5.1.4 Global Implantable Drug Delivery Devices Sales Value by Region (%), (2020-2031)
5.2 Global Implantable Drug Delivery Devices Sales Volume by Region
5.2.1 Global Implantable Drug Delivery Devices Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Implantable Drug Delivery Devices Sales Volume by Region (2020-2025)
5.2.3 Global Implantable Drug Delivery Devices Sales Volume by Region (2026-2031)
5.2.4 Global Implantable Drug Delivery Devices Sales Volume by Region (%), (2020-2031)
5.3 Global Implantable Drug Delivery Devices Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Implantable Drug Delivery Devices Sales Value, 2020-2031
5.4.2 North America Implantable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Implantable Drug Delivery Devices Sales Value, 2020-2031
5.5.2 Europe Implantable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Implantable Drug Delivery Devices Sales Value, 2020-2031
5.6.2 Asia Pacific Implantable Drug Delivery Devices Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Implantable Drug Delivery Devices Sales Value, 2020-2031
5.7.2 South America Implantable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Implantable Drug Delivery Devices Sales Value, 2020-2031
5.8.2 Middle East & Africa Implantable Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Implantable Drug Delivery Devices Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Implantable Drug Delivery Devices Sales Value and Sales Volume
6.2.1 Key Countries/Regions Implantable Drug Delivery Devices Sales Value, 2020-2031
6.2.2 Key Countries/Regions Implantable Drug Delivery Devices Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Implantable Drug Delivery Devices Sales Value, 2020-2031
6.3.2 United States Implantable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Implantable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Implantable Drug Delivery Devices Sales Value, 2020-2031
6.4.2 Europe Implantable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Implantable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Implantable Drug Delivery Devices Sales Value, 2020-2031
6.5.2 China Implantable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.5.3 China Implantable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Implantable Drug Delivery Devices Sales Value, 2020-2031
6.6.2 Japan Implantable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Implantable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Implantable Drug Delivery Devices Sales Value, 2020-2031
6.7.2 South Korea Implantable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Implantable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Implantable Drug Delivery Devices Sales Value, 2020-2031
6.8.2 Southeast Asia Implantable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Implantable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Implantable Drug Delivery Devices Sales Value, 2020-2031
6.9.2 India Implantable Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.9.3 India Implantable Drug Delivery Devices Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 BD
7.1.1 BD Company Information
7.1.2 BD Introduction and Business Overview
7.1.3 BD Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BD Implantable Drug Delivery Devices Product Offerings
7.1.5 BD Recent Development
7.2 B.Braun
7.2.1 B.Braun Company Information
7.2.2 B.Braun Introduction and Business Overview
7.2.3 B.Braun Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 B.Braun Implantable Drug Delivery Devices Product Offerings
7.2.5 B.Braun Recent Development
7.3 AngioDynamics
7.3.1 AngioDynamics Company Information
7.3.2 AngioDynamics Introduction and Business Overview
7.3.3 AngioDynamics Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 AngioDynamics Implantable Drug Delivery Devices Product Offerings
7.3.5 AngioDynamics Recent Development
7.4 ICU Medical
7.4.1 ICU Medical Company Information
7.4.2 ICU Medical Introduction and Business Overview
7.4.3 ICU Medical Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 ICU Medical Implantable Drug Delivery Devices Product Offerings
7.4.5 ICU Medical Recent Development
7.5 Fresenius
7.5.1 Fresenius Company Information
7.5.2 Fresenius Introduction and Business Overview
7.5.3 Fresenius Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Fresenius Implantable Drug Delivery Devices Product Offerings
7.5.5 Fresenius Recent Development
7.6 Vygon
7.6.1 Vygon Company Information
7.6.2 Vygon Introduction and Business Overview
7.6.3 Vygon Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Vygon Implantable Drug Delivery Devices Product Offerings
7.6.5 Vygon Recent Development
7.7 PFM Medical
7.7.1 PFM Medical Company Information
7.7.2 PFM Medical Introduction and Business Overview
7.7.3 PFM Medical Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 PFM Medical Implantable Drug Delivery Devices Product Offerings
7.7.5 PFM Medical Recent Development
7.8 Districlass
7.8.1 Districlass Company Information
7.8.2 Districlass Introduction and Business Overview
7.8.3 Districlass Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Districlass Implantable Drug Delivery Devices Product Offerings
7.8.5 Districlass Recent Development
7.9 Linhwa
7.9.1 Linhwa Company Information
7.9.2 Linhwa Introduction and Business Overview
7.9.3 Linhwa Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Linhwa Implantable Drug Delivery Devices Product Offerings
7.9.5 Linhwa Recent Development
7.10 Sophysa
7.10.1 Sophysa Company Information
7.10.2 Sophysa Introduction and Business Overview
7.10.3 Sophysa Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Sophysa Implantable Drug Delivery Devices Product Offerings
7.10.5 Sophysa Recent Development
7.11 Baxter
7.11.1 Baxter Company Information
7.11.2 Baxter Introduction and Business Overview
7.11.3 Baxter Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Baxter Implantable Drug Delivery Devices Product Offerings
7.11.5 Baxter Recent Development
7.12 PakuMed
7.12.1 PakuMed Company Information
7.12.2 PakuMed Introduction and Business Overview
7.12.3 PakuMed Implantable Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 PakuMed Implantable Drug Delivery Devices Product Offerings
7.12.5 PakuMed Recent Development
8 Industry Chain Analysis
8.1 Implantable Drug Delivery Devices Industrial Chain
8.2 Implantable Drug Delivery Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Implantable Drug Delivery Devices Sales Model
8.5.2 Sales Channel
8.5.3 Implantable Drug Delivery Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer